| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $11.5M | +67.1% |
| SG&A Expense | $8.8M | +86.9% |
| Operating Income | -$27.5M | -126.9% |
| Pre-tax Income | -$27.4M | -129.3% |
| Income Tax | -$531K | +0.0% |
| Net Income | -$27.4M | -140.0% |
| EPS (Basic) | -$1.70 | -126.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.5M | -60.6% |
| Current Assets | $8.4M | -54.2% |
| Total Assets | $8.6M | -67.4% |
| Current Liabilities | $999K | +2.8% |
| Total Liabilities | $1.1M | +17.4% |
| Stockholders' Equity | $7.5M | -70.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.6M | -10.2% |
| Financing Cash Flow | -$389K | -104.0% |